Nephros Inc risk profile
20 Normal where most of the sector sits
Measured 1 September 2026 from NEPH's filed statements. Recomputed nightly.
20 (Normal), driven by Market expectation at 65, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 65 | Stretched | Volatile | One-year price volatility — 87.3% |
| Operating pressure | 9 | Contained | Worsening | Costs outgrowing revenue — -7.8 percentage points |
| Cash conversion | 31 | Normal | Easing | Cash conversion — 1.34x |
| Leverage and coverage | 2 | Contained | Stable | Current ratio — 4.06x |
| Competitive position | 20 | Normal | Stable | R&D-intensity gap against peers — -56.3 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.